Strategies for organ level tissue engineering

Organogenesis

Volumn 6, Issue 3, 2010, Pages 151-157

  Rustad, Kristine C ^a   Sorkin, Michael ^a   Levi, Benjamin ^a   Longaker, Michael T ^a   Gurtner, Geoffrey C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose derived stromal cells; Biomaterials; Growth factors; Regenerative medicine; Scale up; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL;

BIOENGINEERING; BIOTECHNOLOGY; HUMAN; NONHUMAN; REVIEW; SCALE UP; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; HUMANS; ORGAN CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77956417278     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.6.3.12139     Document Type: Review

References (94)

1. The Organ procurement and transplant network/scientific registry of transplant recipients annual report: U.S. department of health & human services 2008.
2. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260:920-6.
3. Ingber DE, Mow VC, Butler D, Niklason L, Huard J, Mao J, et al. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 2006; 12:3265-83.
4. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009; 8:457-70.
5. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367:1241-6.
6. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372:2023-30.
7. Yanaga H, Imai K, Fujimoto T, Yanaga K. Generating ears from cultured autologous auricular chondrocytes by using two-stage implantation in treatment of microtia. Plast Reconstr Surg 2009; 124:817-25.
8. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344:385-6.
9. Warnke PH, Springer IN, Wiltfang J, Acil Y, Eufinger H, Wehmoller M, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004; 364:766-70.
10. Hench LL. Biomaterials. Science 1980; 208:826-31.
11. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002; 295:1014-7.
12. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science 2005; 310:1135-8.
13. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005; 4:518-24.
14. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol 2007; 213:565-73.
15. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009; 326:1216-9.
16. Boland T, Xu T, Damon B, Cui X. Application of inkjet printing to tissue engineering. Biotechnol J 2006; 1:910-7.
17. Atala A. Engineering organs. Curr Opin Biotechnol 2009; 20:575-92.
18. Roth EA, Xu T, Das M, Gregory C, Hickman JJ, Boland T. Inkjet printing for high-throughput cell patterning. Biomaterials 2004; 25:3707-15.
19. Nakamura M, Kobayashi A, Takagi F, Watanabe A, Hiruma Y, Ohuchi K, et al. Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng 2005; 11:1658-66.
20. Ilkhanizadeh S, Teixeira AI, Hermanson O. Inkjet printing of macromolecules on hydrogels to steer neural stem cell differentiation. Biomaterials 2007; 28:3936-43.
21. Bartolovic K, Mongkoldhumrongkul N, Waddington SN, Jayasinghe SN, Howe SJ. The differentiation and engraftment potential of mouse hematopoietic stem cells is maintained after bio-electrospray. Analyst 2010; 135:157-64.
22. Jayasinghe SN, Irvine S, McEwan JR. Cell electrospinning highly concentrated cellular suspensions containing primary living organisms into cell-bearing threads and scaffolds. Nanomedicine (Lond) 2007; 2:555-67.
23. Sahoo S, Lee WC, Goh JC, Toh SL. Bio-electrospraying: a potentially safe technique for delivering progenitor cells. Biotechnol Bioeng 2010.
24. Visconti RP, Kasyanov V, Gentile C, Zhang J, Markwald RR, Mironov V. Towards organ printing: engineering an intra-organ branched vascular tree. Expert Opin Biol Ther 2010; 10:409-20.
25. Mironov V, Visconti RP, Kasyanov V, Forgacs G, Drake CJ, Markwald RR. Organ printing: tissue spheroids as building blocks. Biomaterials 2009; 30:2164-74.
26. Zhang X, Deng Z, Wang H, Yang Z, Guo W, Li Y, et al. Expansion and delivery of human fibroblasts on micronized acellular dermal matrix for skin regeneration. Biomaterials 2009; 30:2666-74.
27. Roessner ED, Thier S, Hohenberger P, Schwarz M, Pott P, Dinter D, et al. Acellular Dermal Matrix Seeded with Autologous Fibroblasts Improves Wound Breaking Strength in a Rodent Soft Tissue Damage Model in Neoadjuvant Settings. J Biomater Appl 2009.
28. Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 1996; 156:571-7.
29. Yoo JJ, Meng J, Oberpenning F, Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 1998; 51:221-5.
30. Probst M, Dahiya R, Carrier S, Tanagho EA. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997; 79:505-15.
31. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14:213-21.
32. Baptista PM, Orlando G, Mirmalek-Sani SH, Siddiqui M, Atala A, Soker S. Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc 2009; 1:6526-9.
33. Asakawa N, Shimizu T, Tsuda Y, Sekiya S, Sasagawa T, Yamato M, et al. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials 2010.
34. Chang EI, Bonillas RG, El-ftesi S, Ceradini DJ, Vial IN, Chan DA, et al. Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds. FASEB J 2009; 23:906-15.
35. Sutherland DE, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery 1977; 82:124-32.
36. Russell PS. Selective transplantation. An emerging concept. Ann Surg 1985; 201:255-62.
37. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988; 23:3-9.
38. Puelacher WC, Mooney D, Langer R, Upton J, Vacanti JP, Vacanti CA. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Biomaterials 1994; 15:774-8.
39. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003; 100:12741-6.
40. Guenou H, Nissan X, Larcher F, Feteira J, Lemaitre G, Saidani M, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009; 374:1745-53.
41. Cowan CM, Shi YY, Aalami OO, Chou YF, Mari C, Thomas R, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nature biotechnology 2004; 22:560-7.
42. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25:2648-59.
43. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, et al. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 2009; 105:648-56.
44. Li W, Wang D, Qin J, Liu C, Zhang Q, Zhang X, et al. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol 2010; 222:492-501.
45. Xu Y, Balooch G, Chiou M, Bekerman E, Ritchie RO, Longaker MT. Analysis of the material properties of early chondrogenic differentiated adipose-derived stromal cells (ASC) using an in vitro three-dimensional micromass culture system. Biochem Biophys Res Commun 2007; 359:311-6.
46. Malladi P, Xu Y, Chiou M, Giaccia AJ, Longaker MT. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physiol 2006; 290:1139-46.
47. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, et al. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment and bone turnover. Tissue Eng 2005; 11:645-58.
48. Quarto N, Longaker MT. Differential expression of specific FGF ligands and receptor isoforms during osteogenic differentiation of mouse Adipose-derived Stem Cells (mASCs) recapitulates the in vivo osteogenic pattern. Gene 2008; 424:130-40.
49. Hammerick KE, James AW, Huang Z, Prinz FB, Longaker MT. Pulsed direct current electric fields enhance osteogenesis in adipose-derived stromal cells. Tissue Eng Part A 2010; 16:917-31.
50. Thangarajah H, Vial IN, Chang E, El-Ftesi S, Januszyk M, Chang EI, et al. IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 2009; 27:266-74.
51. Rodbell M. Metabolism of Isolated Fat Cells I. Effects of Hormones on Glucose Metabolism and Lipolysis. J Biol Chem 1964; 239:375-80.
52. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84:1663-70.
53. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7:211-28.
54. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 2006; 206:229-37.
55. Yang M, Ma QJ, Dang GT, Ma K, Chen P, Zhou CY. In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7. Cytotherapy 2005; 7:273-81.
56. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005; 328:258-64.
57. Ogawa R, Mizuno H, Hyakusoku H, Watanabe A, Migita M, Shimada T. Chondrogenic and osteogenic differentiation of adipose-derived stem cells isolated from GFP transgenic mice. J Nippon Med Sch 2004; 71:240-1.
58. Huang JI, Zuk PA, Jones NF, Zhu M, Lorenz HP, Hedrick MH, et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg 2004; 113:585-94.
59. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174:101-9.
60. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28:875-84.
61. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84:4164-73.
62. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells - their utility and potential in bone formation. Int J Obes Relat Metab Disord 2000; 24:41-4.
63. Lendeckel S, Jodicke A, Christophis P, Heidinger K, Wolff J, Fraser JK, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32:370-3.
64. Mesimaki K, Lindroos B, Tornwall J, Mauno J, Lindqvist C, Kontio R, et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. International journal of oral and maxillofacial surgery 2009; 38:201-9.
65. Kulakov AA, Goldshtein DV, Grigoryan AS, Rzhaninova AA, Alekseeva IS, Arutyunyan IV, et al. Clinical study of the efficiency of combined cell transplant on the basis of multipotent mesenchymal stromal adipose tissue cells in patients with pronounced deficit of the maxillary and mandibulary bone tissue. Bulletin of experimental biology and medicine 2008; 146:522-5.
66. Mao JJ, Giannobile WV, Helms JA, Hollister SJ, Krebsbach PH, Longaker MT, et al. Craniofacial tissue engineering by stem cells. Journal of dental research 2006; 85:966-79.
67. Levi B, James AW, Nelson ER, Vistnes D, Wu B, Lee M, et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS ONE 2009; Submitted.
68. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-76.
69. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-72.
70. Pera MF. Stem cells. A new year and a new era. Nature 2008; 451:135-6.
71. Koh CJ, Atala A. Tissue engineering, stem cells and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 2004; 15:1113-25.
72. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 2001; 344:1511-4.
73. Kato R, Iejima D, Agata H, Asahina I, Okada K, Ueda M, et al. A Compact, Automated Cell Culture System for Clinical Scale Cell Expansion from Primary Tissues. Tissue Eng Part C Methods 2010.
74. Pramatarov I. Investigation of the incidence of silicosis and silicotuberculosis in BCG-vaccinated underground workers of the Rodopsk Coal Basin. Gig Tr Prof Zabol 1965; 9:41-3.
75. Dai J, Rabie AB. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007; 86:937-50.
76. Chiu LL, Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010; 31:226-41.
77. Hao X, Silva EA, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007; 75:178-85.
78. Murakami M, Simons M. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol 2008; 15:215-20.
79. Moya ML, Lucas S, Francis-Sedlak M, Liu X, Garfinkel MR, Huang JJ, et al. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc Res 2009; 78:142-7.
80. Freeman I, Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009; 30:2122-31.
81. Dodla MC, Bellamkonda RV. Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. Biomaterials 2008; 29:33-46.
82. Levenberg S, Burdick JA, Kraehenbuehl T, Langer R. Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue Eng 2005; 11:506-12.
83. Midha R, Munro CA, Dalton PD, Tator CH, Shoichet MS. Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J Neurosurg 2003; 99:555-65.
84. Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing - past, present and future perspectives. Surgeon 2008; 6:172-7.
85. Roberts AB. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen 1995; 3:408-18.
86. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004; 35:562-9.
87. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, et al. Regenerative Medicine Special Feature: Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 2010; 107:3287-92.
88. Tessmar JK, Gopferich AM. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59:274-91.
89. Zhang S, Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009; 26:1561-80.
90. Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010; 31:1242-50.
91. Nagaoka M, Jiang HL, Hoshiba T, Akaike T, Cho CS. Application of Recombinant Fusion Proteins for Tissue Engineering. Ann Biomed Eng 2010.
92. Geutjes PJ, Nillesen ST, Lammers G, Daamen WF, van Kuppevelt TH. Cloning, large-scale production and purification of active dimeric rat vascular endothelial growth factor (rrVEGF-164). Protein Expr Purif 2010; 69:76-82.
93. Pang Y, Wang X, Ucuzian AA, Brey EM, Burgess WH, Jones KJ, et al. Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials 2010; 31:878-85.
94. Joung YK, Bae JW, Park KD. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert Opin Drug Deliv 2008; 5:1173-84.